Nestler J E, Bamberger M, Rothblat G H, Strauss J F
Endocrinology. 1985 Aug;117(2):502-10. doi: 10.1210/endo-117-2-502.
In order to study the metabolism of high density lipoprotein (HDL)-carried sterol in the rat, human HDL was reconstituted with [14C]cholesterol and [3H]cholesteryl ester. After iv injection into immature PMSG-human CG primed rats pretreated with 4-aminopyrazolopyrimidine and aminoglutethimide, there was time-dependent accumulation of 3H and 14C in various organs which reached a maximum by 15-90 min. On a milligram wet weight basis, uptake of 3H and 14C was greatest in the adrenals, next in ovaries, followed by the liver, with little uptake by kidneys and spleen. On an organ basis, accumulation was greatest by the liver. At 15-45 min post injection, 60% of the 3H in the ovary was in free sterol, indicating hydrolysis of the accumulated cholesteryl esters, whereas 95% of the 3H in serum remained in sterol esters associated with HDL. Coadministration of excess unlabeled HDL, but not human low density lipoprotein, reduced accumulation of radioactivity by the ovaries and adrenals by 60%, indicating a specific and saturable uptake process. Granulosa cells cultured in lipoprotein-deficient medium with reconstituted HDL formed 3H- and 14C-labeled 20 alpha-hydroxypregn-4-en-3-one. Over a 24-h period, utilization of both [14C]cholesterol and [3H]cholesteryl ester was linear, but rates of utilization of the two sterol moieties were not parallel. There was preferential uptake and utilization of free sterol. A dose-response study demonstrated a Michaelis-Menten constant (Km) of 40-60 micrograms sterol/ml for both free and esterified cholesterol. Lysosomotropic agents (chloroquine and NH4Cl) had no effect on utilization of either free or esterified cholesterol for steroidogenesis but reduced degradation of 125I-labeled low density lipoprotein apoprotein. These findings lend further support to the concept of a distinct HDL pathway in steroidogenic cells of the rat, which involves 1) preferential uptake and utilization of free cholesterol from HDL and 2) does not require lysosomal activity.
为了研究大鼠体内高密度脂蛋白(HDL)携带的甾醇的代谢,用[14C]胆固醇和[3H]胆固醇酯重构人HDL。将其静脉注射到用4-氨基吡唑并嘧啶和氨基谷氨酰胺预处理的未成熟PMSG-人绒毛膜促性腺激素致敏大鼠体内后,3H和14C在各器官中的积累呈时间依赖性,在15 - 90分钟时达到最大值。以毫克湿重计,肾上腺对3H和14C的摄取量最大,其次是卵巢,然后是肝脏,肾脏和脾脏的摄取量很少。以器官计,肝脏中的积累量最大。注射后15 - 45分钟,卵巢中60%的3H存在于游离甾醇中,表明积累的胆固醇酯发生了水解,而血清中95%的3H仍存在于与HDL相关的甾醇酯中。同时给予过量未标记的HDL,但不给予人低密度脂蛋白,可使卵巢和肾上腺的放射性积累减少60%,表明存在特异性和可饱和的摄取过程。在缺乏脂蛋白的培养基中用重构的HDL培养的颗粒细胞形成了3H和14C标记的20α-羟基孕-4-烯-3-酮。在24小时内,[14C]胆固醇和[3H]胆固醇酯的利用均呈线性,但两种甾醇部分的利用速率并不平行。游离甾醇有优先摄取和利用的情况。剂量反应研究表明,游离胆固醇和酯化胆固醇的米氏常数(Km)均为40 - 60微克甾醇/毫升。溶酶体促渗剂(氯喹和NH4Cl)对游离或酯化胆固醇用于类固醇生成的利用没有影响,但减少了125I标记的低密度脂蛋白载脂蛋白的降解。这些发现进一步支持了大鼠类固醇生成细胞中存在独特HDL途径的概念,该途径涉及1)优先从HDL摄取和利用游离胆固醇,以及2)不需要溶酶体活性。